Cryogenic OGS

How has been the historical performance of Cryogenic OGS?

Cryogenic OGS has shown steady growth in net sales and profitability over the past three years, with net sales increasing from 22.02 Cr in Mar'23 to 32.90 Cr in Mar'25, and profit after tax rising from 4.08 Cr to 6.09 Cr. The company maintains a healthy balance sheet with no long-term borrowings and improved cash flow.

Answer:<BR>The historical performance of Cryogenic OGS shows a steady growth in net sales and profitability over the past three years.<BR><BR>Breakdown:<BR>Cryogenic OGS has demonstrated a consistent increase in net sales, rising from 22.02 Cr in Mar'23 to 24.25 Cr in Mar'24, and further to 32.90 Cr in Mar'25. Total operating income mirrored this trend, reaching 32.90 Cr in Mar'25. However, raw material costs also increased significantly, from 11.70 Cr in Mar'23 to 21.26 Cr in Mar'25. The total expenditure, excluding depreciation, rose from 16.37 Cr in Mar'23 to 24.94 Cr in Mar'25, yet the operating profit (PBDIT) improved from 6.34 Cr in Mar'23 to 8.85 Cr in Mar'25. Profit before tax also saw an upward trajectory, increasing from 5.48 Cr in Mar'23 to 8.27 Cr in Mar'25, while profit after tax rose from 4.08 Cr to 6.09 Cr in the same period. The earnings per share (EPS) increased from 3.89 in Mar'23 to 5.8 in Mar'25. On the balance sheet, total assets grew from 23.95 Cr in Mar'23 to 33.73 Cr in Mar'25, with total liabilities also increasing from 23.95 Cr to 33.73 Cr. The company maintained no long-term borrowings, and cash and cash equivalents rose from 8.10 Cr in Mar'23 to 11.07 Cr in Mar'25, indicating a positive cash flow position. Overall, Cryogenic OGS has shown robust growth in sales and profitability, alongside a healthy balance sheet.

Is Cryogenic OGS overvalued or undervalued?

As of October 17, 2025, Cryogenic OGS is considered very expensive and overvalued with a PE ratio of 42.91, despite recent strong stock returns of 17.08% and 22.98% over the past week and month, respectively, making it an unfavorable investment at its current price of 183.00.

As of 17 October 2025, the valuation grade for Cryogenic OGS has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its key financial ratios, including a PE ratio of 42.91, an EV to EBITDA ratio of 29.49, and a Price to Book Value of 5.23. <BR><BR>When compared to its peers, Cryogenic OGS stands out with a higher PE ratio than Thermax at 55.98 and BEML Ltd at 61.47, both of which are also classified as very expensive. The company has shown strong returns over the past week and month, outperforming the Sensex with a stock return of 17.08% and 22.98%, respectively. However, despite these short-term gains, the overall valuation suggests that Cryogenic OGS is not a favorable investment at its current price of 183.00.

Why is Cryogenic OGS Ltd falling/rising?

As of 02-Feb, Cryogenic OGS Ltd's stock price is Rs 174.55, reflecting a 3.28% increase. The stock has shown strong recent performance, outperforming the benchmark Sensex, but there is a decline in investor participation indicated by a drop in delivery volume.

As of 02-Feb, Cryogenic OGS Ltd's stock price is rising, currently at Rs 174.55, which reflects a change of Rs 5.55 or 3.28% increase. This upward movement is supported by the stock's performance today, where it outperformed the sector by 3.51%. The stock reached an intraday high of Rs 174.55, indicating strong buying interest at this price point.<BR><BR>In the context of recent performance, the stock has shown a positive trend over the past week, with a return of +3.07%, while the benchmark Sensex only increased by +0.16%. Year-to-date, Cryogenic OGS Ltd has also performed well, with a return of +7.09%, contrasting with the Sensex's decline of -4.17%. <BR><BR>However, it is important to note that there has been a decline in investor participation, as evidenced by a significant drop in delivery volume by -45.12% compared to the 5-day average. Additionally, while the stock is trading above its 5-day, 20-day, and 200-day moving averages, it is below its 50-day and 100-day moving averages, which may indicate some volatility in the stock's performance.<BR><BR>Overall, the combination of a positive price change today, strong recent performance relative to the benchmark, and the stock's ability to reach a high intraday price contributes to the current rise in Cryogenic OGS Ltd's stock price.

Which are the latest news on Cryogenic OGS?